| Role of Tofacitinib in Vitiligo Patients (NCT05293119) | Pi Research Consultancy Center, Bangladesh | 2022-05-30 |
| A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo (NCT05247489) | Incyte Corporation | 2022-05-05 |
| Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. (NCT05513924) | South Valley University | 2022-03-15 |
| Ocular Changes in Vitiligo Patients on Therapy (NCT05335746) | Benha University | 2022-03-10 |
| Defining the Role of the Skin Microbiome in Immune-related Adverse Events (NCT04734704) | University Hospital, Bordeaux | 2022-01-11 |
| Improved Phototherapy in Patients With Vitiligo (NCT05836441) | The First Affiliated Hospital with Nanjing Medical University | 2022-01-01 |
| Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo (NCT05121532) | Sohag University | 2022-01-01 |
| Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment (NCT04738149) | Medical University of South Carolina | 2021-11-02 |
| The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic (NCT05098600) | Faculty Hospital Kralovske Vinohrady | 2021-10-15 |
| Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo (NCT04971200) | Premier Specialists, Australia | 2021-09-16 |
| Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo (NCT04872257) | Hospital Universitario Dr. Jose E. Gonzalez | 2021-09-14 |
| Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma (NCT03155698) | Assiut University | 2021-08-01 |
| Hair Transplantation for Treatment of Vitiligo (NCT04858152) | Mehdi Rashighi | 2021-08-01 |
| Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo (NCT05506995) | Universidad Autonoma de San Luis Potosí | 2021-08-01 |
| A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo (NCT05053022) | Crown Laboratories, Inc. | 2021-07-29 |
| Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo (NCT04822584) | University Hospital, Bordeaux | 2021-07-16 |
| A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) (NCT04896385) | Incyte Corporation | 2021-06-23 |
| Mental Health Associations With Vitiligo (NCT04953338) | Momentum Data | 2021-06-18 |
| Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo (NCT04969419) | Momentum Data | 2021-06-18 |
| ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation (NCT04843059) | Centre Hospitalier Universitaire de Nice | 2021-06-01 |
| Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up (NCT04789993) | Central Hospital, Nancy, France | 2021-03-15 |
| Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo (NCT04811131) | Arcutis Biotherapeutics, Inc. | 2021-03-04 |
| Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo (NCT04765826) | Alexandria University | 2021-01-25 |
| Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo (NCT05233735) | Tel-Aviv Sourasky Medical Center | 2021-01-01 |
| Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo (NCT04577027) | Assiut University | 2021-01-01 |
| Resident Memory T Cells in Vitiligo (NCT05223738) | Kasr El Aini Hospital | 2020-12-31 |
| Evaluation of AMG 714 for Vitiligo (NCT04338581) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-12-11 |
| Tofacitinib for Immune Skin Conditions in Down Syndrome (NCT04246372) | University of Colorado, Denver | 2020-10-21 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions (NCT04271501) | Avita Medical | 2020-09-25 |
| Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo (NCT04530344) | Incyte Corporation | 2020-09-24 |
| Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo (NCT04320160) | Assiut University | 2020-08-01 |
| Efficacy of Red Light in the Treatment of Pigmentary Disorders (NCT04308421) | University of British Columbia | 2020-03-01 |
| Correlation of Glucose and Lipid Metabolism Levels With Vitiligo (NCT05968235) | Xijing Hospital | 2020-02-01 |
| Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo (NCT04774809) | Reistone Biopharma Company Limited | 2020-01-29 |
| Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata (NCT03976622) | University Hospital, Bordeaux | 2020-01-14 |
| Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo (NCT04171427) | Laboratoire Dermatologique ACM | 2019-11-21 |
| Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo (NCT04103060) | Dermavant Sciences GmbH | 2019-09-27 |
| Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt (NCT04039451) | Assiut University | 2019-09-01 |
| Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo (NCT03973073) | Peking University People's Hospital | 2019-08-01 |
| E-cadherin and Integrin Alpha v Beta 1 in Vitiligo (NCT05287776) | Kasr El Aini Hospital | 2019-06-01 |
| The Gut and Skin Microbiome in Vitiligo Disease Progression (NCT03577327) | Northwestern University | 2019-05-30 |
| PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation (NCT03933774) | The Catholic University of Korea | 2019-04-29 |
| Human Beta-defensin 1 in Vitiligo (NCT03832751) | Cairo University | 2019-03-01 |
| Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo (NCT03872804) | Alexandria University | 2019-02-01 |
| A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC (NCT03661866) | Target PharmaSolutions, Inc. | 2018-12-21 |
| Prostaglandin F2-alpha (PGF2α) in Vitiligo (NCT03755830) | Cairo University | 2018-12-01 |
| Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo (NCT03158675) | Assiut University | 2018-12-01 |
| Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB (NCT04030988) | Ain Shams University | 2018-11-01 |
| Microneedling and Latanoprost in Acrofacial Vitiligo (NCT03611348) | Sohag University | 2018-09-01 |
| The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity (NCT03741738) | Yonsei University | 2018-08-30 |
| Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo (NCT03622320) | Cairo University | 2018-07-01 |
| Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo (NCT03608917) | xjpfW | 2018-04-17 |
| A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo (NCT03468855) | Aclaris Therapeutics, Inc. | 2018-03-19 |
| Comparative Study of Surgical Treatment of Vitiligo (NCT03497208) | Hospital de Clinicas de Porto Alegre | 2018-03-13 |
| Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in Non Cultured Epidermal Cell Suspension in Stable Vitiligo (NCT03668834) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2018-01-01 |
| Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo (NCT03384342) | The Catholic University of Korea | 2017-11-18 |
| Maintenance Therapy of 308-nm Excimer Laser Therapy in Patients With Vitiligo (NCT03384459) | The Catholic University of Korea | 2017-11-18 |
| Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo (NCT03365141) | The Catholic University of Korea | 2017-11-14 |
| Photoprotection Habits in Patients With Vitiligo (NCT03323125) | Assistance Publique - Hôpitaux de Paris | 2017-10-16 |
| Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo (NCT03358082) | Sohag University | 2017-10-01 |
| Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo (NCT04374435) | University of California, Irvine | 2017-09-29 |
| Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients (NCT03717025) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2017-07-01 |
| A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo (NCT03099304) | Incyte Corporation | 2017-06-07 |
| Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo (NCT03123016) | Icahn School of Medicine at Mount Sinai | 2017-04-14 |
| Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO (NCT03036995) | Centre Hospitalier Universitaire de Nice | 2017-03-20 |
| Evaluation of Scanoskin for the Assessment of Vitiligo (NCT03133871) | Chelsea and Westminster NHS Foundation Trust | 2017-03-01 |
| Thymic Stromal Lymphopoietin (TSLP) in Vitiligo (NCT03367273) | Cairo University | 2017-01-01 |
| ReNovaCell in Non-segmental Vitiligo (NCT03022019) | Netherlands Institute for Pigment Disorders | 2016-12-01 |
| Secukinumab in Active Non-segmental Vitiligo (NCT05676333) | University Hospital, Ghent | 2016-10-12 |
| Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo (NCT02925767) | The Catholic University of Korea | 2016-08-01 |
| Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo (NCT03859518) | Centre Hospitalier Universitaire de Nice | 2016-07-01 |
| Long-term Follow-up in Patients Affected With Acrofacial Vitiligo (NCT01459055) | Irmandade da Santa Casa de Misericordia de Curitiba | 2016-05-01 |
| Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score (NCT03411135) | Cairo University | 2016-04-01 |
| Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo (NCT02962180) | Mohammed V Souissi University | 2016-03-01 |
| Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC (NCT02466997) | University Hospital, Bordeaux | 2016-02-23 |
| A Novel Surgical Method in the Treatment of Unstable Vitiligo (NCT03013049) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2016-01-01 |
| Topical Ruxolitinib for the Treatment of Vitiligo (NCT02809976) | Tufts Medical Center | 2016-01-01 |
| Janus Kinase 1 in Vitiligo & Psoriasis (NCT03762551) | Cairo University | 2015-12-01 |
| Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo (NCT03249064) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2015-10-27 |
| Stress Response Pathways in Vitiligo (NCT02797574) | NYU Langone Health | 2015-10-01 |
| Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo (NCT03047733) | Ajou University School of Medicine | 2015-07-21 |
| Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo (NCT02506101) | Johns Hopkins University | 2015-07-01 |
| Atorvastatin in Active Vitiligo (NCT02432534) | Centre Hospitalier Universitaire de Nice | 2015-05-01 |
| Fractional Laser in Combination With UVB Therapy in Vitiligo Patients (NCT02290717) | Netherlands Institute for Pigment Disorders | 2015-05-01 |
| Open-label Pilot Study of Abatacept for the Treatment of Vitiligo (NCT02281058) | Brigham and Women's Hospital | 2015-01-01 |
| Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo (NCT02191748) | Rutgers, The State University of New Jersey | 2014-09-01 |
| To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study (NCT03864315) | National Taiwan University Hospital | 2014-07-01 |
| Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV) (NCT04525157) | Clinuvel Pharmaceuticals Limited | 2014-06-06 |
| Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism (NCT02156427) | Laboratoires Genévrier | 2014-04-29 |
| Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo (NCT02625012) | Juan Pablo Castanedo-Cazares | 2014-01-01 |
| Photocil (Topical) for the Treatment of Vitiligo (NCT01992185) | Applied Biology, Inc. | 2013-08-01 |
| NB-UVB and PUVA Vitiligo Study (NCT01732965) | Henry Ford Health System | 2013-03-01 |
| UVA 1 Phototherapy for Vitiligo (NCT01787695) | University of British Columbia | 2013-02-01 |
| Efficacy of Red Light in Vitiligo (NCT01787708) | University of British Columbia | 2013-02-01 |
| Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand (NCT01792245) | University of British Columbia | 2013-02-01 |
| Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo (NCT01766609) | University of British Columbia | 2013-01-01 |
| HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home (NCT01478945) | University of Nottingham | 2012-02-01 |
| Clinical Trial of Simvastatin to Treat Generalized Vitiligo (NCT01517893) | John Harris | 2012-01-01 |
| Efficacy and Safety of ACH24 in the Treatment of Vitiligo (NCT01419964) | Ache Laboratorios Farmaceuticos S.A. | 2012-01-01 |